Funded Tech Companies

DiCE Molecules

Operating out of San Francisco, DiCE Molecules has funding from Sands Capital Management, Soleus Capital and New Leaf Venture Partners.

Company Overview

Contact Information

Company Background Information

Overview

At DiCE Molecules, we design and develop innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/25/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Judice

        

Chief Financial Officer

Scott Robertson

        

Chief Medical Officer

Timothy Lu

        

Vice President

Paul Fatheree

        

Vice President

Nico Ghilardi

        

Vice President

John Jacobsen

        

Vice President

Meina Tang

        

Company Investors

• Sands Capital Management
• Soleus Capital
• New Leaf Venture Partners
• Osage Partners
• Deep Track Capital
• Northpond Ventures
• Logos Capital
• RA Capital (Jake Simson)
• Asymmetry Capital Management
• Driehaus Capital Management
• Eventide Asset Management
• Janus Henderson Investors
• Sanofi-Genzyme BioVentures
• Alexandria Venture Investments
• Altitude Life Science Ventures
• Agent Capital

Browse more funded tech companies:

Dice | DiCentral

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary